180 Life Sciences Corp. (ATNF)

0.90

0.02 (2.28%)

At close: Apr 28, 2025, 3:56 PM

0.86

-3.98%

After-hours: Apr 28, 2025, 06:03 PM EDT

180 Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	105.67K	109K	116.3K	125.33K	72.24K	n/a	n/a
Gross Profit	n/a	-105.67K	-109K	-116.3K	-125.33K	-72.24K	n/a	n/a
Operating Income	-6.32M	-13.48M	-17.9M	-15.64M	-5.65M	-20.86M	-8.74M	-343.88K
Interest Income	n/a	n/a	26.67K	186.21K	1.09M	181.41K	12.23K	663.02K
Pretax Income	-6.46M	-22.28M	-39.67M	-20.35M	-10.9M	-25.4M	-14.5M	319.13K
Net Income	-6.17M	-19.94M	-38.73M	-20.32M	-12.01M	-25.39M	-14.5M	123.76K
Selling & General & Admin	4.36M	10.69M	15.47M	11.69M	3.36M	18.85M	7.67M	343.88K
Research & Development	1.4M	2.78M	2.43M	3.95M	2.29M	2.04M	1.07M	n/a
Other Expenses	567.83K	n/a	246.34B	770.6K	264.74K	250.4K	n/a	n/a
Operating Expenses	6.32M	13.48M	39.64M	20.16M	9.82M	25.22M	14.51M	343.88K
Interest Expense	-50.64K	44.83	26.67K	186.21K	1.09M	185.14K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	38.83K	12.96M	n/a	n/a
Cost & Expenses	n/a	13.48M	39.64M	20.16M	9.82M	25.22M	14.51M	343.88K
Income Tax Expense	-296.02K	-2.35M	942.75K	23.2K	20.43K	9.5K	-1	195.37K
Shares Outstanding (Basic)	915.37K	379K	100K	82K	47K	29K	10K	10K
Shares Outstanding (Diluted)	915.37K	379.09K	100.02K	82.51K	47.77K	29.04K	10K	10K
EPS (Basic)	-6.74	-52.6	-387.26	-247.86	-255.46	-875.66	-1.45K	12.38
EPS (Diluted)	-6.74	-52.59	-387.18	-246.32	-251.32	-874.45	-1.45K	12.38
EBITDA	-6.32M	-22.13M	-17.79M	-20.05M	-5.52M	-20.79M	-8.72M	-343.88K
EBIT	-6.51M	-22.24M	-17.9M	-15.64M	-5.65M	-20.86M	-8.74M	n/a
Depreciation & Amortization	190.11K	105.67K	109K	116.3K	125.33K	72.24K	23.08K	52.52K